Business Information
The group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The group produces a natural human alpha interferon product under the tradename of multiferontmfrom human white blood cells, also known as leukocytes. Natural interferon-alpha is one of the body's most important natural defense mechanisms to foreign substances like viruses, but it also stimulates and modulates the human immune system. In addition, interferon inhibits the growth of various viruses including those associated with diseases like hepatitis, some types of cancer, multiple sclerosis, and severe acute respiratory syndrome (sars). The group is a majority owned subsidiary of viragen, inc.
|
|
Name |
Title
|
Email
|
| Carl Singer | Chmn. | N/A | | orjan Norberg | MD - Viranative AB | N/A | | Dennis Healey | Dir., CFO | N/A | | Charles Rice | Dir., CEO, Pres. | N/A | | Patrick Yeramian | Consulting Medical Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 391 | (8,516) | | 2005 | 279 | (15,644) | | 2004 | 266 | (7,076)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
